Correlation Between Acumen Pharmaceuticals and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Tscan Therapeutics, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Tscan Therapeutics.
Diversification Opportunities for Acumen Pharmaceuticals and Tscan Therapeutics
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Acumen and Tscan is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Tscan Therapeutics
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Tscan Therapeutics. In addition to that, Acumen Pharmaceuticals is 1.07 times more volatile than Tscan Therapeutics. It trades about -0.15 of its total potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.05 per unit of volatility. If you would invest 489.00 in Tscan Therapeutics on August 28, 2024 and sell it today you would lose (37.00) from holding Tscan Therapeutics or give up 7.57% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Acumen Pharmaceuticals vs. Tscan Therapeutics
Performance |
Timeline |
Acumen Pharmaceuticals |
Tscan Therapeutics |
Acumen Pharmaceuticals and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acumen Pharmaceuticals and Tscan Therapeutics
The main advantage of trading using opposite Acumen Pharmaceuticals and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.Acumen Pharmaceuticals vs. Eliem Therapeutics | Acumen Pharmaceuticals vs. HCW Biologics | Acumen Pharmaceuticals vs. Scpharmaceuticals | Acumen Pharmaceuticals vs. Milestone Pharmaceuticals |
Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |